These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells. Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879 [TBL] [Abstract][Full Text] [Related]
4. 1 alpha,25-Dihydroxyvitamin D3 rapidly alters phospholipid metabolism in the nuclear envelope of osteoblasts. Sorensen AM; Baran DT J Cell Biochem; 1995 May; 58(1):15-21. PubMed ID: 7642719 [TBL] [Abstract][Full Text] [Related]
5. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Dokoh S; Donaldson CA; Haussler MR Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of 1,25-dihydroxyvitamin D3 on cytosolic calcium in two human cell lines (HL-60 and U-937). Desai SS; Appel MC; Baran DT J Bone Miner Res; 1986 Dec; 1(6):497-501. PubMed ID: 3503560 [TBL] [Abstract][Full Text] [Related]
7. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Norman AW; Sergeev IN; Bishop JE; Okamura WH Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333 [TBL] [Abstract][Full Text] [Related]
8. 1 alpha,25-dihydroxyvitamin D3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression. Jenis LG; Lian JB; Stein GS; Baran DT J Cell Biochem; 1993 Nov; 53(3):234-9. PubMed ID: 8263040 [TBL] [Abstract][Full Text] [Related]
9. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3. Van Auken M; Buckley D; Ray R; Holick MF; Baran DT J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881 [TBL] [Abstract][Full Text] [Related]
10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related]
11. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element. Uchida M; Ozono K; Pike JW J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065 [TBL] [Abstract][Full Text] [Related]
12. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3. Bouillon R; Sarandeses LA; Allewaert K; Zhao J; MascareƱas JL; MouriƱo A; Vrielynck S; de Clercq P; Vandewalle M J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251 [TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia). Zhou LX; Nemere I; Norman AW J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106 [TBL] [Abstract][Full Text] [Related]
14. Binding characteristics of a membrane receptor that recognizes 1 alpha,25-dihydroxyvitamin D3 and its epimer, 1 beta,25-dihydroxyvitamin D3. Baran DT; Ray R; Sorensen AM; Honeyman T; Holick MF J Cell Biochem; 1994 Dec; 56(4):510-7. PubMed ID: 7890809 [TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Mosavin R; Mellon WS Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719 [TBL] [Abstract][Full Text] [Related]
16. The effect of 1,25-dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells. Gronowicz G; Egan JJ; Rodan GA J Bone Miner Res; 1986 Oct; 1(5):441-55. PubMed ID: 3332554 [TBL] [Abstract][Full Text] [Related]
17. 1 alpha,25-dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: inhibition by pertussis toxin and 1 beta,25-dihydroxyvitamin D3. Baran DT; Sorensen AM; Honeyman TW; Ray R; Holick MF J Bone Miner Res; 1990 May; 5(5):517-24. PubMed ID: 2368631 [TBL] [Abstract][Full Text] [Related]
18. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Arbour NC; Prahl JM; DeLuca HF Mol Endocrinol; 1993 Oct; 7(10):1307-12. PubMed ID: 8264662 [TBL] [Abstract][Full Text] [Related]
19. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene. Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149 [TBL] [Abstract][Full Text] [Related]
20. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Farach-Carson MC; Sergeev I; Norman AW Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]